Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic

L H Sehn1, P Kuruvilla2, A Christofides3

  • 1BC Cancer, Centre for Lymphoid Cancer, and University of British Columbia, Vancouver, BC.

Insights

The COVID-19 pandemic necessitates updated chronic lymphocytic leukemia (CLL) treatment guidelines. This summary reviews American Society of Hematology (ASH) recommendations for managing CLL patients during the pandemic in Canada.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Oncology

Background:

  • The COVID-19 pandemic has significantly impacted clinical practices for patients with chronic lymphocytic leukemia (CLL).
  • Hematologists require updated guidance for managing CLL patients amidst the global health crisis.

Purpose of the Study:

  • To summarize the American Society of Hematology (ASH) recommendations for CLL patient care during the COVID-19 pandemic.
  • To discuss the applicability of these ASH guidelines within the Canadian healthcare context.

Main Methods:

  • Review and synthesis of published ASH recommendations.
  • Analysis of the relevance and implementation of these recommendations for Canadian CLL patient management.

Main Results:

  • ASH provides comprehensive guidance on COVID-19 testing, CLL treatment initiation and selection, immunoglobulin therapy, monitoring, and managing co-infected patients.
  • The recommendations offer a framework for adapting CLL care during the pandemic.

Conclusions:

  • ASH guidelines offer crucial direction for managing chronic lymphocytic leukemia patients during the COVID-19 pandemic.
  • These recommendations are adaptable for Canadian clinicians to ensure optimal patient care and safety.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...